A proposed rule by the Centers for Medicare & Medicaid Services that denies payment if a home infusion provider is not present at the time services are rendered has drawn the ire of the National Home Infusion Association and other key stakeholders.
If adopted, critics contend, the rule will prevent reimbursement for care planning, sterile compounding and other critical off-site services that often are an essential part of high-quality home infusion therapy.
As part of the proposed rule,